Relmada Therapeutics, Inc. (GETTEX:4E2) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles J. Casamento Other companies: GT Biopharma, Inc. (Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past); International Stem Cell Corporation (Director · Mar 31, 2016 – Jun 21, 2018 · Past) | Chairman of the Board · Since at least Oct 20, 2017 |
| Douglas Beck Other companies: SHF Holdings, Inc. (PAO SVP of Finance Controller · Since at least Sep 24, 2025); ShiftPixy Inc (Chief Financial Officer · Jan 15, 2023 – Jan 15, 2023 · Past); Beyond Air, Inc. (Chief Financial Officer · Nov 1, 2018 – Jun 16, 2021 · Past); iBio, Inc. (Chief Financial Officer · May 3, 2011 – May 3, 2011 · Past); Lev Pharmaceuticals Inc (Chief Financial Officer · Jun 7, 2006 – Jun 7, 2006 · Past) | Chief Financial Officer · Jan 6, 2015 – Feb 23, 2015 · Past |
| Eric Thomas Schmidt Other companies: Revolution Medicines, Inc. (Director · Jun 17, 2020 – Jun 8, 2023 · Past); Allogene Therapeutics, Inc. (Chief Financial Officer · Oct 10, 2018 – Mar 22, 2023 · Past) | Director · Dec 19, 2019 – May 25, 2023 · Past |
| Maged Shenouda Other companies: GridAI Technologies Corp. (CHIEF FINANCIAL OFFICER, Director · Oct 11, 2016 – Dec 28, 2018 · Past); Protea Biosciences Group (Director · Apr 17, 2015 – Dec 18, 2015 · Past) | Chief Financial Officer · Since at least Nov 12, 2015 |
| Chuck Ence Other companies: Newage Inc (Chief Financial Officer · Sep 15, 2016 – Sep 15, 2016 · Past) | Chief Accounting and Compliance Officer · Since at least Jul 29, 2019 |
| Lisa Nolan Other companies: Opus Genetics, Inc. (Chief Business Officer · Jul 6, 2016 – Feb 28, 2019 · Past) | Chief Business Officer · Dec 14, 2015 – Dec 14, 2015 · Past |
| Sandesh Seth Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Chief Executive Officer and Chairman of the Board · Since at least Dec 28, 2012) | Director · Jan 6, 2015 – Dec 15, 2015 · Past |
| Sergio Traversa Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Director · Dec 28, 2012 – Mar 14, 2017 · Past) | Chief Executive Officer · Since at least Jan 6, 2015 |
| Thomas Wessel Other companies: Decoy Therapeutics Inc. (Chief Medical Officer · Jan 17, 2018 – Jan 17, 2018 · Past) | EVP, Head of R&D · Mar 9, 2020 – Mar 9, 2020 · Past |
| Bipin Dalmia | Chief Business Officer · Since Jul 28, 2026 |
| Cedric O'Gorman | Chief Medical Officer · Jan 6, 2023 – May 23, 2023 · Past |
| Fabiana Fedeli | Director · Since at least Jan 12, 2023 |
| John Glasspool | Director · Since at least Dec 17, 2021 |
| Jørn Skibsted Jakobsen | Chief Development Officer, Urology & Uro-Oncology · Since Nov 16, 2026 |
| Nabil Yazgi | Director · Jan 6, 2015 – Jan 6, 2015 · Past |
| Ottavio V Vitolo | CMO · Apr 2, 2018 – Dec 19, 2019 · Past |
| Paul Kelly | Chief Operating Officer · Since at least Nov 12, 2015 |
| Shreeram Agharkar | Director · Dec 16, 2015 – Dec 31, 2015 · Past |
| Yair Lotan | Chair of Relmada’s Clinical Advisory Board · Jul 15, 2025 – Nov 4, 2026 · Past |